Axsome Therapeutics Inc (AXSM)

[someconcerns]

Print Format
Change Text Size:

Default text sizeA Larger text sizeA Largest text sizeA

Axsome Therapeutics to Report Second Quarter 2022 Financial Results on August 9, 2022
BY GlobeNewswire
— 7:00 AM ET 07/28/2022

Axsome to host conference call and webcast on Tuesday, August 9, 2022 at 8:00 AM Eastern Time

NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (AXSM) , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that it will report its financial results for the second quarter of 2022 on Tuesday, August 9, 2022 before the opening of the U.S. financial markets. Axsome’s management team will host a conference call at 8:00 AM Eastern Time on August 9, 2022 to discuss these results and provide a business update.

To participate in the live conference call, please dial [phone] (toll-free domestic). A live webcast of the conference call can be accessed on the “Webcasts & Presentations” page of the “Investors” section of the Company’s website at www.axsome.com. A recording of the conference call will be available on the Company’s website for approximately 30 days following the live event.